Tableaux’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
229
0.12% 93
2026
Q1
$211K Sell
229
-41
-15% -$41.6K 0.1% 108
2025
Q4
$290K Sell
270
-644
-70% -$616K 0.21% 68
2025
Q3
$697K Buy
914
+457
+100% +$340K 0.28% 50
2025
Q2
$356K Hold
457
0.2% 85
2025
Q1
$377K Buy
457
+23
+5% +$19.1K 0.27% 57
2024
Q4
$335K Buy
+434
New +$359K 0.28% 49

Other funds holding LLY

Tableaux's LLY Position: Q2 2026 in Review

Tableaux held its Eli Lilly (LLY) position steady in Q2 2026 at 229 shares worth $275K. The position accounts for 0.12% of the portfolio, ranked #93.

Tableaux first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $697K in Q3 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tableaux held 229 shares of Eli Lilly worth $275K as of Q2 2026.
  • Tableaux left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.12% of Tableaux's portfolio in Q2 2026, its #93 holding.
  • Tableaux first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Tableaux's Eli Lilly position peaked at $697K in Q3 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tableaux's 13F filing for Q2 2026, filed 7 Aug 2026.